Uploaded October 2025 | Updated September 2026, 2 weeks ago
Women around the world continue to face unequal access to prevention, diagnosis, and treatment for Non-Communicable Diseases (NCDs). Gender bias, late detection, and limited research focused on women slow progress and lead to poorer outcomes. These barriers contribute to a persistent gender gap in global health.
This session explores how women-centric approaches can improve equity in NCD care. It highlights why women remain underrepresented in clinical studies and how this limits innovation. The discussion focuses on practical solutions for stronger prevention, earlier diagnosis, and better access to quality care.
Experts from policy, civil society, academia, and industry share their perspectives. They discuss how countries and partners can allocate resources more fairly, even when health budgets are under pressure. The session also examines the diseases that drive most of the gender health gap, including ischemic heart disease, cervical cancer, and breast cancer.
Contributions come from Melinda Crane-Roehrs, Ilona Kickbusch (Graduate Institute Geneva), Markus Kosch (Daiichi Sankyo Europe), Phoebe Ongadi (KENCO), Sara Nasser (Charité and Policlinico Agostino Gemelli IRCCS), Hiroyuki Okuzawa (Daiichi Sankyo), Alarcos Cieza (WHO), and Stine Bosse (European Parliament). Together, they outline actions needed to close the gender gap in NCDs across countries and populations.
The World Health Summit is the leading global platform bringing together science, politics, civil society, and the private sector to catalyze collaborative and innovative solutions for key health priorities. Learn more at www.worldhealthsummit.org.
Women around the world continue to face unequal access to prevention, diagnosis, and treatment for Non-Communicable Diseases (NCDs). Gender bias, late detection, and limited research focused on women slow progress and lead to poorer outcomes. These barriers contribute to a persistent gender gap in global health.
This session explores how women-centric approaches can improve equity in NCD care. It highlights why women remain underrepresented in clinical studies and how this limits innovation. The discussion focuses on practical solutions for stronger prevention, earlier diagnosis, and better access to quality care.
Experts from policy, civil society, academia, and industry share their perspectives. They discuss how countries and partners can allocate resources more fairly, even when health budgets are under pressure. The session also examines the diseases that drive most of the gender health gap, including ischemic heart disease, cervical cancer, and breast cancer.
Contributions come from Melinda Crane-Roehrs, Ilona Kickbusch (Graduate Institute Geneva), Markus Kosch (Daiichi Sankyo Europe), Phoebe Ongadi (KENCO), Sara Nasser (Charité and Policlinico Agostino Gemelli IRCCS), Hiroyuki Okuzawa (Daiichi Sankyo), Alarcos Cieza (WHO), and Stine Bosse (European Parliament). Together, they outline actions needed to close the gender gap in NCDs across countries and populations.
The World Health Summit is the leading global platform bringing together science, politics, civil society, and the private sector to catalyze collaborative and innovative solutions for key health priorities. Learn more at www.worldhealthsummit.org.
